GovChime
Notice ID: a509948806dd4ec197bcfd82ad154320Combined Synopsis/Solicitation

Acquisition of cGMP-grade GS-441524 for the Treatment of COVID-19

Archived on February 8, 2022. Original response deadline: . Full description on SAM.gov.

Overview

Response deadline
9:00 AM UTC−05:00
Posted
February 1, 2022
Notice type
Combined Synopsis/Solicitation
Agency
Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH

Notice details

Office
NATIONAL INSTITUTES OF HEALTH NIDA
Last updated
Sep 9, 2025

Identifiers

Solicitation number
75N95022Q00102
Notice ID
a509948806dd4ec197bcfd82ad154320

Description

THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME). The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Avisa Pharma Solutions, Inc. (dba Cambrex), 3501 Tricenter Blvd Ste C, Durham, NC 27713-1868. To ensure consistency among material, the current requirement must be manufactured by the same vendor that is manufacturing the non-GMP material for the same project under Contract No. 75N95021P00063. Therefore, this acquisition is restricted to Avisa Pharma Solutions, Inc. (dba Cambrex). The purpose of this acquisition is to obtain 2-3Kg of cGMP GS-441524. See attachments for complete requirement details.

Full description on SAM.gov

Award Overview

No prior contract identified

No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.

Contacts

Documents

No documents available.

Lifecycle

Solicitation:75N95022Q00102
  1. Combined Synopsis
  1. Combined SynopsisCurrentFeb 1, 2022

    Acquisition of cGMP-grade GS-441524 for the Treatment of COVID-19

    Notice a509948806dd4ec197bcfd82ad154320 on SAM.gov

Similar Opportunities

Title
Match
Phase
Deadline

Additional Details

Solicitation Number

75N95022Q00102

Archive Date

Feb 8, 2022

Office Address

Bethesda, MD, 20892